IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1531 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (867 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed3304    
    Printed119    
    Emailed0    
    PDF Downloaded180    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR - CASE LETTER
Year : 2015  |  Volume : 81  |  Issue : 5  |  Page : 537-539

Cetirizine-induced urticaria masquerading as multiple drug intolerance syndrome


1 Department of Dermatology and Venereology, Employee's State Insurance Corporation Medical College and Hospital, NH3, NIT Faridabad (Haryana), India
2 Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India

Date of Web Publication28-Aug-2015

Correspondence Address:
Dr. Vinod K Sharma
Department of Dermatology, Venereology, and Leprology, All India Institute of Medical Sciences, New Delhi - 110 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.162338

Rights and Permissions



How to cite this article:
Singh S, Kumar P, Sharma VK. Cetirizine-induced urticaria masquerading as multiple drug intolerance syndrome. Indian J Dermatol Venereol Leprol 2015;81:537-9

How to cite this URL:
Singh S, Kumar P, Sharma VK. Cetirizine-induced urticaria masquerading as multiple drug intolerance syndrome. Indian J Dermatol Venereol Leprol [serial online] 2015 [cited 2020 Jun 5];81:537-9. Available from: http://www.ijdvl.com/text.asp?2015/81/5/537/162338


Sir,

Drug reactions in dermatology are an enigma and the tough part is to identify the culprit drug in the current era of poly-pharmacy. We report an interesting case of oral cetirizine-induced urticarial eruption in a patient complaining of intolerance to multiple drugs.

A 39-year-old woman complainted of evanescent skin eruptions following the intake of several oral medications. During each episode, the patient had taken drugs and developed a generalized eruption of itchy wheals within 8-10 h of drug intake, not associated with angioedema. She had six such episodes over the previous 8 months. For the first episode, she was treated with intramuscular injections of chlorpheniramine maleate and dexamethasone with which the rash subsided in 2-3 h. On other occasions, the rash subsided spontaneously within 3-5 h. The list of drugs that she had received prior to the onset of symptoms on various occasions included cetirizine, levocetirizine, hydroxyzine, fexofenadine, ebastine, cyproheptadine, paracetamol, omeprazole, esomeprazole, cefixime, ivermectin, escitalopram and clonazepam. Consequently, the patient had developed drug phobia and was moderately distressed. There was no history of spontaneous urticaria or angioedema, systemic symptoms, atopy or any other drug allergies. Clinical examination was within normal limits. Her baseline complete blood counts, liver and kidney function tests, antinuclear antibody level, urine and stool examination were all within normal limits. Her chest X-ray and abdomino-pelvic ultrasonography did not reveal any abnormality.

We admitted her to the inpatient department and carried out a supervised, patient blinded, placebo-controlled oral drug provocation test by standard methods [Table 1]. [1] Four hours after taking a tablet of cetirizine 10 mg, she developed generalized discrete to confluent wheals (associated with pruritus but not angioedema) which subsided spontaneously after 7-8 h [Figure 1] and [Figure 2]. She developed a few wheals after taking a tablet of diclofenac, 25 mg and mild pruritus following intake of a tablet of fexofenadine, 120 mg [Table 1]. Oral levocetirizine provocation could not be performed as she declined any further oral drug provocation. Intradermal testing done with injections pheniramine maleate (22.75 mg/ml) and hydroxyzine hydrochloride (25 mg/ml) was negative. An injectable formulation of cetirizine was not available and was hence not tested.
Figure 1: Erythematous, discrete to confluent, tiny urticarial wheals over both forearms


Click here to view
Figure 2: Erythematous, discrete to confluent, diffuse urticarial eruption over the neck and upper chest


Click here to view
Table 1: Schedule of oral drug provocation testing and the results


Click here to view


The patient was relieved of her drug phobia when the results were conveyed to her. On repeat interviewing, it was revealed that all her 6 episodes of urticaria had been preceded by cetirizine intake and fexofenadine had been taken prior to one of the episodes. Cetirizine had been taken (in combination with several drugs listed above) twice for itching, twice for fever with exanthemata, once for urinary tract infection and genital burning, and once for abdominal pain. Diclofenac had not been taken by the patient in the past 8 months. She was advised to avoid cetirizine in the future and to take diclofenac and fexofenadine with caution, if required. Till date, over an 18-month follow up, the patient has been avoiding cetirizine and levocetirizine, has taken fexofenadine on and off for non-dermatological indications and does not report any recurrence of urticarial lesions. She also remains free of any drug phobia.

Drug provocation testing is considered to be the gold standard for the diagnosis of drug reactions and is broadly useful in the following three situations: to make a definitive diagnosis of drug hypersensitivity, to provide a list of safe alternative drugs in patients known to have drug hypersensitivities, and to exclude either drug hypersensitivities or cross reactivity between different drugs.

Multiple drug hypersensitivity or intolerance syndrome was initially defined as intolerance to two or more chemically unrelated, mainly antibiotic drugs [2] but Schiavino et al. defined it as intolerance to 3 or more unrelated medications. [3] It often culminates in patients getting anxious and being wary of medications. Ramam et al. conducted oral drug provocation testing on self-reported multiple drug reactors and did not find any patient qualifying as a multiple drug reactor. They concluded that such patients possibly suffer from drug phobia rather than true allergies. [4]

Cetirizine is considered safe and commonly used as a first line drug in many allergic disorders including urticarias, but quite ironically it has been documented to cause or aggravate urticaria. [5],[6],[7],[8] Although the exact mechanism behind cetirizine-induced urticaria is unknown, suggested mechanisms include a non-immunological response, non-specific mast cell or alternate complement pathway activation. [5],[6],[7] Chang et al. found urticarial reactions to both cetirizine and hydroxyzine but not to levocetirizine. A probable role of the dextrocetirizine enantiomer in causing urticaria and the structural similarity between cetirizine and hydroxyzine were suggested as explanations. [7] However, hydroxyzine did not produce urticaria in our case, which may be due to the relatively stable hydroxyl group on hydroxyzine (vis-a-vis the acidic carboxyl group on cetirizine).

Non-steroidal anti-inflammatory drugs non-specifically increase histamine release from basophils and are known to aggravate or cause urticaria by decreasing prostaglandin E 2 (PGE 2) levels. [9] This may have been the reason for positive provocation to diclofenac in our patient. Since it was not historically relevant, our patient could not be labeled as a case of multiple drug intolerance syndrome even though she developed urticaria to more than 1 drug during the testing process.

We therefore conclude that drug provocation testing may be the only way to resolve the issue of suspected multi-drug allergy and that cetirizine, among other H1 antihistaminic drugs, should also be kept in the list of suspected drugs whenever relevant.

 
  References Top

1.
Ramam M, Kumar U, Bhat R, Sharma VK. Oral drug provocation test to generate a list of safe drugs: Experience with 100 patients. Indian J Dermatol Venereol Leprol 2012;78:595-8.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.
Sullivan T, Remedios C, Ong M, Gilliam LK. Studies of the multiple drug allergy syndrome. J Allergy Clin Immunol 1989;83:270.  Back to cited text no. 2
    
3.
Schiavino D, Nucera E, Roncallo C, Pollastrini E, De Pasquate T, Lombardo C, et al. Multiple drug intolerance syndrome: Clinical findings and usefulness of challenge tests. Ann Allergy Asthma Immunol 2007;99:136-42.  Back to cited text no. 3
    
4.
Ramam M, Bhat R, Jindal S, Kumar U, Sharma VK, Sagar R, et al. Patient reported multiple drug reactions: Clinical profile and results of challenge testing. Indian Dermatol Venereol Leprol 2010;76:382-6.  Back to cited text no. 4
    
5.
Calista D, Schianchi S, Morri M. Urticaria induced by cetirizine. Br J Dermatol 2001;144:196.  Back to cited text no. 5
    
6.
Schroter S, Damveld B, Marsch WC. Urticarial inrolerance reaction to cetirizine. Clin Exp Dermatol 2002;27:185-7.  Back to cited text no. 6
    
7.
Chang YS, Kwon HS, Cho SH, Kim YY, Min KU. A case of urticaria induced by both hydroxyzine and cetirizine but not by levocetirizine. Allergy 2007;62:819-21.  Back to cited text no. 7
    
8.
Karamfilov T, Wilmer A, Hipler UC, Wollina U. Cetirizine induced urticarial reaction. Br J Dermatol 1999;140:979-80.  Back to cited text no. 8
    
9.
Matsuo H, Yokooji T, Morita H, Ooi M, Urata K, Ishii K, et al. Aspirin augments IgE-mediated histamine release from human peripheral basophils via Syk kinase activation. Allergol Int 2013;62:503-11.  Back to cited text no. 9
    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1]

This article has been cited by
1 Cetirizine
Reactions Weekly. 2015; 1571(1): 51
[Pubmed] | [DOI]



 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow